The Early Glycoprotein IIb/IIIa Inhibition in Non–ST-Segment Elevation Acute Coronary Syndrome (EARLY ACS) trial: A randomized placebo-controlled trial evaluating the clinical benefits of early front-loaded eptifibatide in the treatment of patients with non–ST-segment elevation acute coronary syndrome—Study design and rationale

Correction to: Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial

Circulation ◽

10.1161/cir.0000000000000640 ◽

2018 ◽

Vol 138 (24) ◽

Keyword(s):

Acute Coronary Syndrome ◽

Standard Care ◽

Controlled Trial ◽

St Segment Elevation ◽

Coronary Syndrome ◽

Randomized Controlled ◽

St Segment ◽

A randomised controlled trial of upstream administration of eptifibatide in patients presenting non-ST segment elevation acute coronary syndrome treated with an invasive strategy

EuroIntervention ◽

10.4244/eijv3i2a39 ◽

2007 ◽

Vol 3 (2) ◽

pp. 228-234 ◽

Cited By ~ 7

Author(s):

Eric Durand ◽

Christian Hamm ◽

Carlos Macaya ◽

Jean-Louis Georges ◽

Pierre Coste ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Invasive Strategy ◽

St Segment Elevation ◽

Coronary Syndrome ◽

St Segment ◽

Elevation Acute Coronary Syndrome ◽

Randomised Controlled

Differences among GP IIb/IIIa inhibitors: different clinical benefits in non-ST-segment elevation acute coronary syndrome percutaneous coronary intervention patients

European Heart Journal Supplements ◽

10.1093/eurheartj/sul069 ◽

2007 ◽

Vol 9 (suppl_A) ◽

pp. A32-A36 ◽

Cited By ~ 4

Author(s):

David Antoniucci

Keyword(s):

Percutaneous Coronary Intervention ◽

Acute Coronary Syndrome ◽

Coronary Intervention ◽

St Segment Elevation ◽

Coronary Syndrome ◽

St Segment ◽

Percutaneous Coronary ◽

Clinical Benefits ◽

Faculty Opinions recommendation of Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.729080920.793537118 ◽

2017 ◽

Author(s):

Nanette Wenger ◽

Niels Engberding

Keyword(s):

Acute Coronary Syndrome ◽

Conservative Treatment ◽

Elderly Patients ◽

Controlled Trial ◽

St Segment Elevation ◽

Coronary Syndrome ◽

Randomized Controlled ◽

St Segment ◽

Response by Kofoed et al to Letter Regarding Article, “Early Versus Standard Care Invasive Examination and Treatment of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial”

Circulation ◽

10.1161/circulationaha.119.040053 ◽

2019 ◽

Vol 139 (20) ◽

Cited By ~ 1

Author(s):

Klaus F. Kofoed ◽

Henning Kelbæk ◽

Thomas Engstrøm ◽

Lars V. Køber

Keyword(s):

Acute Coronary Syndrome ◽

Standard Care ◽

Controlled Trial ◽

St Segment Elevation ◽

Coronary Syndrome ◽

Randomized Controlled ◽

St Segment ◽

Letter by Bonello et al Regarding Article, “Early Versus Standard Care Invasive Examination and Treatment of Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: VERDICT Randomized Controlled Trial”

Circulation ◽

10.1161/circulationaha.118.037810 ◽

2019 ◽

Vol 139 (20) ◽

Author(s):

Laurent Bonello ◽

Marc Laine ◽

Gilles Lemesle

Keyword(s):

Acute Coronary Syndrome ◽

Standard Care ◽

Controlled Trial ◽

St Segment Elevation ◽

Coronary Syndrome ◽

Randomized Controlled ◽

St Segment ◽

Baseline indicators of coronary artery disease burden in patients with non-ST-segment elevation acute coronary syndrome

Minerva Cardioangiologica ◽

10.23736/s0026-4725.19.04838-2 ◽

2019 ◽

Vol 67 (3) ◽

Cited By ~ 1

Author(s):

Konrad Stepien ◽

Karol Nowak ◽

Pawel Skorek ◽

Veranika Baravik ◽

Anna Kozynacka ◽

...

Keyword(s):

Coronary Artery Disease ◽

Acute Coronary Syndrome ◽

Coronary Artery ◽

Disease Burden ◽

St Segment Elevation ◽

Coronary Syndrome ◽

St Segment ◽

Elevation Acute Coronary Syndrome ◽

Artery Disease

Faculty of 1000 evaluation for Causes of death in patients ≥75 years of age with non-ST-segment elevation acute coronary syndrome.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717995954.793476260 ◽

2013 ◽

Author(s):

Philip Liebson

Keyword(s):

Acute Coronary Syndrome ◽

Causes Of Death ◽

St Segment Elevation ◽

Coronary Syndrome ◽

St Segment ◽

Prasugrel Versus Ticagrelor in Non–ST-Segment Elevation Acute Coronary Syndrome

Journal of the American College of Cardiology ◽

10.1016/j.jacc.2020.12.061 ◽

2021 ◽

Vol 77 (11) ◽

pp. 1483-1484

Author(s):

Chia Siang Kow ◽

Abdullah Faiz Zaihan ◽

Syed Shahzad Hasan

Keyword(s):

Acute Coronary Syndrome ◽

St Segment Elevation ◽

Coronary Syndrome ◽

St Segment ◽

Baseline CHA 2 DS 2 ‐VASc score and prognosis in octogenarians with non‐ST segment elevation acute coronary syndrome

International Journal of Clinical Practice ◽

10.1111/ijcp.14082 ◽

2021 ◽

Author(s):

Pablo Díez‐Villanueva ◽

Alberto Vera ◽

Albert Ariza‐Solé ◽

Francesc Formiga ◽

Manuel Martínez‐Sellés ◽

...

Keyword(s):

Acute Coronary Syndrome ◽

St Segment Elevation ◽

Coronary Syndrome ◽

St Segment ◽